What Is Digital Diagnostics?
Digital Diagnostics is a healthcare technology company that develops autonomous artificial intelligence for medical diagnosis. Its flagship product, LumineticsCore, analyzes retinal images to detect diabetic retinopathy. The system was originally called IDx-DR. It received FDA authorization in April 2018, marking an important milestone for autonomous diagnostic AI. Digital Diagnostics+1
What Can Digital Diagnostics Do?
LumineticsCore evaluates retinal images captured during diabetic eye screening. It detects more than mild diabetic retinopathy in eligible adults with diabetes. The system generates a diagnostic report without requiring a physician to interpret the images.
The product supports point-of-care screening in primary care settings. This allows healthcare providers to identify patients who need further eye-care assessment during routine visits.
LumineticsCore is intended for adults aged 22 or older with diabetes who have not previously been diagnosed with diabetic retinopathy. It does not replace a comprehensive eye examination. Patients with findings requiring further assessment should receive appropriate eye-care referral. Digital Diagnostics+1
Who Uses Digital Diagnostics?
Primary care clinics, healthcare providers and health systems can use LumineticsCore in diabetic eye screening programmes. The workflow supports providers who want to assess retinal images without sending every patient for an initial specialist interpretation.
Digital Diagnostics Pricing and Access
Digital Diagnostics does not display a standard public subscription price for LumineticsCore. Healthcare providers can contact the company to discuss product access, implementation and commercial terms. The product is intended for clinical use rather than general consumer diagnosis.
Learn more about Digital Diagnostics: LumineticsCore Product.




